blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2508624

EP2508624 - Polynucleotide primers for detecting pik3ca mutations [Right-click to bookmark this link]
Former [2012/41]Polynucleotide primers for detecting PIK3CA mutations
[2014/39]
StatusNo opposition filed within time limit
Status updated on  20.11.2015
Database last updated on 31.08.2024
Most recent event   Tooltip20.07.2018Lapse of the patent in a contracting state
New state(s): PT		published on 22.08.2018  [2018/34]
Applicant(s)For all designated states
QIAGEN Manchester Limited
Skelton House Lloyd Street North
Manchester M15 6SH / GB
[2012/41]
Inventor(s)01 / Board, Ruth
c/o Christi Hospital
Wilmslow Road
Manchester M20 4BX / GB
02 / Ferguson, Jennifer
c/o Qiagen Manchester Limited
Skelton House
Lloyd Street North
Manchester M15 6SH / GB
03 / Ravetto, Paul Francis
c/o Qiagen Manchester Limited
Skelton House
Lloyd Street North
Manchester M15 6SH / GB
04 / Thelwell, Nicola
c/o Qiagen Manchester Limited
Skelton House
Lloyd Street North
Manchester M15 6SH / GB
05 / Whitcombe, David
Larkspur Hall
Rosslyn Lane
Cuddington, Northwich Cheshire CW8 2JZ / GB
 [2012/41]
Representative(s)CH Kilger Anwaltspartnerschaft mbB
Fasanenstraße 29
10719 Berlin / DE
[N/P]
Former [2012/41]Fanelli Haag Kilger PLLC
Fasanenstrasse 29
10719 Berlin / DE
Application number, filing date12169604.129.09.2008
[2012/41]
Priority number, dateGB2007001903428.09.2007         Original published format: GB 0719034
[2012/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2508624
Date:10.10.2012
Language:EN
[2012/41]
Type: B1 Patent specification 
No.:EP2508624
Date:14.01.2015
Language:EN
[2015/03]
Search report(s)(Supplementary) European search report - dispatched on:EP12.09.2012
ClassificationIPC:C12Q1/68
[2012/41]
CPC:
C12Q1/6886 (EP,CN,GB,KR,US); C12N15/11 (GB); C12Q1/6827 (GB,KR);
C12Q1/6844 (US); C12Q1/6883 (US); C12Q2600/156 (EP,CN,KR,US);
C12Q2600/158 (US); C12Q2600/16 (EP,CN,KR,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2012/41]
TitleGerman:Polynukleotidprimer zum Nachweis von Mutationen des PIK3CA-Gens[2012/41]
English:Polynucleotide primers for detecting pik3ca mutations[2014/47]
French:Amorces de polynucléotides pour la detection de mutations dans le gène PIK3CA[2012/41]
Former [2012/41]Polynucleotide primers for detecting PIK3CA mutations
Examination procedure15.02.2013Amendment by applicant (claims and/or description)
15.02.2013Examination requested  [2013/13]
22.03.2013Despatch of a communication from the examining division (Time limit: M06)
27.09.2013Reply to a communication from the examining division
31.01.2014Despatch of a communication from the examining division (Time limit: M04)
04.06.2014Reply to a communication from the examining division
24.10.2014Communication of intention to grant the patent
01.12.2014Receipt of the translation of the claim(s)
02.12.2014Fee for grant paid
02.12.2014Fee for publishing/printing paid
Parent application(s)   TooltipEP08806456.3  / EP2205760
Opposition(s)15.10.2015No opposition filed within time limit [2015/52]
Fees paidRenewal fee
22.06.2012Renewal fee patent year 03
22.06.2012Renewal fee patent year 04
20.09.2012Renewal fee patent year 05
20.09.2013Renewal fee patent year 06
26.09.2014Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.09.2008
AT14.01.2015
BE14.01.2015
CY14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
FI14.01.2015
HR14.01.2015
LT14.01.2015
LV14.01.2015
MC14.01.2015
MT14.01.2015
NL14.01.2015
PL14.01.2015
PT14.01.2015
RO14.01.2015
SE14.01.2015
SI14.01.2015
SK14.01.2015
TR14.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
IE29.09.2015
LU29.09.2015
[2018/34]
Former [2017/40]HU29.09.2008
AT14.01.2015
BE14.01.2015
CY14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
FI14.01.2015
HR14.01.2015
LT14.01.2015
LV14.01.2015
MC14.01.2015
MT14.01.2015
NL14.01.2015
PL14.01.2015
RO14.01.2015
SE14.01.2015
SI14.01.2015
SK14.01.2015
TR14.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
IE29.09.2015
LU29.09.2015
Former [2017/22]AT14.01.2015
BE14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
FI14.01.2015
HR14.01.2015
LT14.01.2015
LV14.01.2015
MC14.01.2015
MT14.01.2015
NL14.01.2015
PL14.01.2015
RO14.01.2015
SE14.01.2015
SI14.01.2015
SK14.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
IE29.09.2015
LU29.09.2015
Former [2016/33]AT14.01.2015
BE14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
FI14.01.2015
HR14.01.2015
LT14.01.2015
LV14.01.2015
MC14.01.2015
NL14.01.2015
PL14.01.2015
RO14.01.2015
SE14.01.2015
SI14.01.2015
SK14.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
IE29.09.2015
LU29.09.2015
Former [2016/24]AT14.01.2015
BE14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
FI14.01.2015
HR14.01.2015
LT14.01.2015
LV14.01.2015
MC14.01.2015
NL14.01.2015
PL14.01.2015
RO14.01.2015
SE14.01.2015
SI14.01.2015
SK14.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
LU29.09.2015
Former [2016/23]AT14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
FI14.01.2015
HR14.01.2015
LT14.01.2015
LV14.01.2015
MC14.01.2015
NL14.01.2015
PL14.01.2015
RO14.01.2015
SE14.01.2015
SI14.01.2015
SK14.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
LU29.09.2015
Former [2016/21]AT14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
FI14.01.2015
HR14.01.2015
LT14.01.2015
LV14.01.2015
NL14.01.2015
PL14.01.2015
RO14.01.2015
SE14.01.2015
SI14.01.2015
SK14.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
LU29.09.2015
Former [2016/12]AT14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
FI14.01.2015
HR14.01.2015
LT14.01.2015
LV14.01.2015
NL14.01.2015
PL14.01.2015
RO14.01.2015
SE14.01.2015
SI14.01.2015
SK14.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
Former [2015/49]AT14.01.2015
CZ14.01.2015
DK14.01.2015
EE14.01.2015
FI14.01.2015
HR14.01.2015
LT14.01.2015
LV14.01.2015
NL14.01.2015
PL14.01.2015
RO14.01.2015
SE14.01.2015
SK14.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
Former [2015/39]AT14.01.2015
FI14.01.2015
HR14.01.2015
LT14.01.2015
LV14.01.2015
NL14.01.2015
PL14.01.2015
SE14.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
Former [2015/38]AT14.01.2015
FI14.01.2015
HR14.01.2015
LT14.01.2015
PL14.01.2015
SE14.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
IS14.05.2015
Former [2015/37]FI14.01.2015
HR14.01.2015
LT14.01.2015
PL14.01.2015
SE14.01.2015
BG14.04.2015
NO14.04.2015
GR15.04.2015
Former [2015/36]FI14.01.2015
HR14.01.2015
LT14.01.2015
SE14.01.2015
BG14.04.2015
NO14.04.2015
Former [2015/35]LT14.01.2015
NO14.04.2015
Documents cited:SearchWO0130362  [ ] (IMMUSOL INC [US], et al);
 EP1266970  [ ] (ORTHO CLINICAL DIAGNOSTICS INC [US]);
 [X]WO2005116265  (WYETH CORP [US], et al);
 [XI]WO2006091899  (AMGEN INC [US], et al);
by applicantEP0332435
 US5210015
 US5487972
 WO9966071
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.